Key Takeaways: Novavax announced that the Biden administration agreed to buy 1.5 million more doses of its protein-based vaccine. The deal would modify a pre-existing contract between Novavax and the US government and allow for the development of smaller doses and the selection of strains according to the FDA’s recommendations. Novavax’s protein-based vaccine is made
This post was created with our nice and easy submission form. Create your post!